Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25690
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-04-11T07:23:17Z-
dc.date.available2022-04-11T07:23:17Z-
dc.date.issued2012-01-
dc.identifier.citationÇelebi, S. vd. (2012). "Neonatal candidiasis: Results of an 8 year study". Pediatrics International, 54(3), 341-349.en_US
dc.identifier.issn1328-8067-
dc.identifier.issn1442-200X-
dc.identifier.urihttps://doi.org/10.1111/j.1442-200X.2012.03574.x-
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/full/10.1111/j.1442-200X.2012.03574.x-
dc.identifier.urihttp://hdl.handle.net/11452/25690-
dc.description.abstractBackground: The aim of the present study was to evaluate the risk factors, demographic features, treatment and clinical outcome associated with candidemia in a neonatal intensive care unit (NICU) within an 8 year period. Methods: The data of infants who were diagnosed as having candidemia, were evaluated. Results: Between January 2000 and December 2007, a total of 28 candidemia episodes were identified in 28 infants. A 1.1% candidemia incidence was documented in the neonatal intensive care unit (NICU). The species most frequently causing candidemia were Candida parapsilosis (57.1%), followed by C. albicans (42.9%). The main predisposing factors for candidemia with C. parapsilosis included presence of maternal pre-eclampsia, prematurity, prolonged mechanical ventilation, prolonged total parenteral nutrition and presence of jaundice. Retinopathy of prematurity and bronchopulmonary dysplasia were the most frequently seen underlying illnesses in infants with C. parapsilosis. In the present study, 13 infants (46.4%) had evidence of organ dissemination. The mortality rate was 42.8% in infants with candidemia. Mean leukocyte counts and mean C-reactive protein were significantly higher in neonates who died compared with those who survived. Conclusion: Candida parapsilosis (57.1%) was the leading causative organism, followed by C. albicans (42.9%) in infants. The rate of organ dissemination in the present cases was high. The mortality rate was 42.8% in infants with candidemia.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPediatricsen_US
dc.subjectInfantsen_US
dc.subjectNeonatal intensive care uniten_US
dc.subjectRisk factors for candidemiaen_US
dc.subjectBlood-stream infectionsen_US
dc.subjectIntensive-care-uniten_US
dc.subjectRisk-factorsen_US
dc.subjectHorizontal transmissionen_US
dc.subjectCandidemiaen_US
dc.subjectEpidemiologyen_US
dc.subjectFluconazoleen_US
dc.subjectSepsisen_US
dc.subjectTherapyen_US
dc.subjectSusceptibilityen_US
dc.subject.meshCandidaen_US
dc.subject.meshCandidemiaen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfant, newbornen_US
dc.subject.meshMaleen_US
dc.subject.meshProspective studiesen_US
dc.subject.meshRisk factorsen_US
dc.subject.meshTime factorsen_US
dc.titleNeonatal candidiasis: Results of an 8 year studyen_US
dc.typeArticleen_US
dc.identifier.wos000304470000014tr_TR
dc.identifier.scopus2-s2.0-84861599755tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı/Çocuk Enfeksiyon Hastalıkları Bölümü.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı/Neonatoloji Bölümü.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-4803-8206tr_TR
dc.identifier.startpage341tr_TR
dc.identifier.endpage349tr_TR
dc.identifier.volume54tr_TR
dc.identifier.issue3tr_TR
dc.relation.journalPediatrics Internationalen_US
dc.contributor.buuauthorÇelebi, Solmaz-
dc.contributor.buuauthorHacımustafaoğlu, Mustafa-
dc.contributor.buuauthorKöksal, Nilgün-
dc.contributor.buuauthorÖzkan, Hilal-
dc.contributor.buuauthorÇetinkaya, Merih-
dc.contributor.buuauthorEner, Beyza-
dc.contributor.researcheridAAG-8393-2021tr_TR
dc.contributor.researcheridAAG-8523-2021tr_TR
dc.identifier.pubmed22320707tr_TR
dc.subject.wosPediatricsen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid7006095295tr_TR
dc.contributor.scopusid6602154166tr_TR
dc.contributor.scopusid7003323615tr_TR
dc.contributor.scopusid16679325400tr_TR
dc.contributor.scopusid23994946300tr_TR
dc.contributor.scopusid15053025300tr_TR
dc.subject.scopusInvasive Candidiasis; Fluconazole; Systemic Mycosisen_US
dc.subject.emtreeAmikacinen_US
dc.subject.emtreeAmphotericin b deoxycholateen_US
dc.subject.emtreeAmphotericin b lipid complexen_US
dc.subject.emtreeAmpicillinen_US
dc.subject.emtreeC reactive proteinen_US
dc.subject.emtreeCarbapenemen_US
dc.subject.emtreeCefotaximeen_US
dc.subject.emtreeCeftazidimeen_US
dc.subject.emtreeFluconazoleen_US
dc.subject.emtreeFlucytosineen_US
dc.subject.emtreeGentamicinen_US
dc.subject.emtreeVancomycinen_US
dc.subject.emtreeApneaen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeArtificial ventilationen_US
dc.subject.emtreeBrainen_US
dc.subject.emtreeCandida albicansen_US
dc.subject.emtreeCandida parapsilosisen_US
dc.subject.emtreeCandidiasisen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeDemographyen_US
dc.subject.emtreeDisease exacerbationen_US
dc.subject.emtreeDrug substitutionen_US
dc.subject.emtreeDrug withdrawalen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFeveren_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeIncidenceen_US
dc.subject.emtreeInfanten_US
dc.subject.emtreeInfant mortalityen_US
dc.subject.emtreeJaundiceen_US
dc.subject.emtreeKidneyen_US
dc.subject.emtreeKlebsiella pneumoniaeen_US
dc.subject.emtreeLeukocyte counten_US
dc.subject.emtreeLung dysplasiaen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNewbornen_US
dc.subject.emtreeNewborn diseaseen_US
dc.subject.emtreeNewborn intensive careen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreeOutcome assessmenten_US
dc.subject.emtreeParenteral nutritionen_US
dc.subject.emtreePeritoneal cavityen_US
dc.subject.emtreePreeclampsiaen_US
dc.subject.emtreePrematurityen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeProspective studyen_US
dc.subject.emtreePseudomonas aeruginosaen_US
dc.subject.emtreeRetrolental fibroplasiaen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeStaphylococcus epidermidisen_US
dc.subject.emtreeStomach distensionen_US
dc.subject.emtreeTachypneaen_US
dc.subject.emtreeTreatment durationen_US
Appears in Collections:PubMed
Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.